Mettler-Toledo International (NYSE:MTD) Sets New 52-Week High - Time to Buy?

Key Points

• Mettler-Toledo International reached a new 52-week high, trading at $1,438.70, with analysts forecasting a consensus price target of $1,336.50 for the stock.
• Recent earnings reports showed the company exceeded analyst estimates with earnings per share of $10.09, which led to various analysts increasing their price targets for the stock.
• Insider selling activity has been observed, with key individuals reducing their ownership significantly, indicating potential shifts in confidence among company insiders.

Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) hit a new 52-week high on Thursday . The company traded as high as $1,438.70 and last traded at $1,436.21, with a volume of 146305 shares trading hands. The stock had previously closed at $1,381.44.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on MTD shares. Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an "outperform" rating in a report on Tuesday, October 7th. Barclays lifted their target price on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an "overweight" rating in a research note on Thursday, October 2nd. Citigroup boosted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research report on Thursday, August 21st. Weiss Ratings restated a "hold (c)" rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a "neutral" rating in a report on Thursday, October 9th. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $1,336.50.

Mettler-Toledo International Price Performance

The firm has a market cap of $29.59 billion, a price-to-earnings ratio of 36.37, a P/E/G ratio of 4.16 and a beta of 1.37. The firm's fifty day moving average is $1,292.42 and its two-hundred day moving average is $1,200.70.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the prior year, the business posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Gerry Keller sold 165 shares of the company's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the sale, the insider owned 94 shares in the company, valued at $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company's stock, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock worth $2,371,208 over the last 90 days. 1.94% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC lifted its holdings in shares of Mettler-Toledo International by 11.2% during the first quarter. GAMMA Investing LLC now owns 327 shares of the medical instruments supplier's stock valued at $386,000 after purchasing an additional 33 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Mettler-Toledo International by 95.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock valued at $2,600,000 after buying an additional 1,073 shares in the last quarter. Blue Trust Inc. lifted its stake in Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after buying an additional 52 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in shares of Mettler-Toledo International in the 1st quarter valued at approximately $714,000. Finally, Asset Management One Co. Ltd. lifted its position in shares of Mettler-Toledo International by 7.8% in the 1st quarter. Asset Management One Co. Ltd. now owns 18,991 shares of the medical instruments supplier's stock valued at $22,427,000 after acquiring an additional 1,382 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.